These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 4067099)
1. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force VI: Arrhythmias. Zipes DP; Cobb LA; Garson A; Gillette PC; James TN; Lazzara R; Rink L J Am Coll Cardiol; 1985 Dec; 6(6):1225-32. PubMed ID: 4067099 [No Abstract] [Full Text] [Related]
2. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias. Zipes DP; Garson A Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S276-83. PubMed ID: 7523824 [No Abstract] [Full Text] [Related]
3. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 6: arrhythmias. Zipes DP; Garson A J Am Coll Cardiol; 1994 Oct; 24(4):892-9. PubMed ID: 7523472 [No Abstract] [Full Text] [Related]
4. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force V: Ischemic heart disease. Epstein SE; Blomqvist CG; Buja LM; Haskell WL; Ryan TJ; Thompson PD J Am Coll Cardiol; 1985 Dec; 6(6):1222-4. PubMed ID: 4067098 [No Abstract] [Full Text] [Related]
5. Cardiovascular evaluation of the young athlete. Strong WB; Steed D Prim Care; 1984 Mar; 11(1):61-75. PubMed ID: 6561685 [TBL] [Abstract][Full Text] [Related]
6. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension. Kaplan NM; Deveraux RB; Miller HS J Am Coll Cardiol; 1994 Oct; 24(4):885-8. PubMed ID: 7930221 [No Abstract] [Full Text] [Related]
7. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 4: systemic hypertension. Kaplan NM; Deveraux RB; Miller HS Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S268-70. PubMed ID: 7934750 [No Abstract] [Full Text] [Related]
8. [Use of Holter/monitoring in sports medicine]. Kogan-Iasnyĭ VV; Ostrogovskaia VA Kardiologiia; 1988 Jul; 28(7):86-8. PubMed ID: 3210532 [No Abstract] [Full Text] [Related]
9. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force IV: Systemic arterial hypertension. Frohlich ED; Lowenthal DT; Miller HS; Pickering T; Strong WB J Am Coll Cardiol; 1985 Dec; 6(6):1218-21. PubMed ID: 4067097 [No Abstract] [Full Text] [Related]
10. [Recommendations for sports participation in patients with arrhythmia]. Milliez P; Haggui A; Maltret A; Leenhardt A Arch Mal Coeur Vaiss; 2006 Nov; 99(11):992-1002. PubMed ID: 17181039 [TBL] [Abstract][Full Text] [Related]
11. [Disorders of cardiac rhythm in top athletes]. Jung K Med Welt; 1974 Feb; 25(7):263-7. PubMed ID: 4816691 [No Abstract] [Full Text] [Related]
12. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. Cheitlin MD; Douglas PS; Parmley WW J Am Coll Cardiol; 1994 Oct; 24(4):874-80. PubMed ID: 7930219 [No Abstract] [Full Text] [Related]
13. 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 2: acquired valvular heart disease. Cheitlin MD; Douglas PS; Parmley WW Med Sci Sports Exerc; 1994 Oct; 26(10 Suppl):S254-60. PubMed ID: 7934748 [No Abstract] [Full Text] [Related]
14. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force III: Hypertrophic cardiomyopathy, other myopericardial diseases and mitral valve prolapse. Maron BJ; Gaffney FA; Jeresaty RM; McKenna WJ; Miller WW J Am Coll Cardiol; 1985 Dec; 6(6):1215-7. PubMed ID: 4067096 [No Abstract] [Full Text] [Related]
15. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force II: Acquired valvular heart disease. Cheitlin MD; Bonow RO; Parmley WW; Roberts WC; Swan HJ; Williams JF J Am Coll Cardiol; 1985 Dec; 6(6):1209-14. PubMed ID: 2856840 [No Abstract] [Full Text] [Related]
16. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force I: Congenital heart disease. McNamara DG; Bricker JT; Galioto FM; Graham TP; James FW; Rosenthal A J Am Coll Cardiol; 1985 Dec; 6(6):1200-8. PubMed ID: 4067095 [No Abstract] [Full Text] [Related]
18. [Ventricular arrhythmia in the athlete: practical management]. Brion R; Van de Walle JP; Caignault JR Rev Prat; 2001 Jun; 51(12 Suppl):S44-50. PubMed ID: 11505868 [TBL] [Abstract][Full Text] [Related]
19. 16th Bethesda Conference: Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. October 3-5, 1984. Mitchell JH; Maron BJ; Epstein SE J Am Coll Cardiol; 1985 Dec; 6(6):1186-232. PubMed ID: 2577752 [No Abstract] [Full Text] [Related]
20. Sports cardiology in the adolescent athlete: concerns for the pediatrician. Washington R Pediatr Ann; 2007 Nov; 36(11):698-702. PubMed ID: 18074985 [No Abstract] [Full Text] [Related] [Next] [New Search]